Higher leukocyte subpopulation counts in healthy smoker industrial workers than in nonsmoker industrial workers: Possible health consequences

Acta Haematologica

Volumn 129, Issue 4, 2013, Pages 218-222

  Azam Mansoor, M ^a   Stakkestad, Jacob A ^b   Drabløs, Per Arne ^c  

^a UNIVERSITY OF AGDER   (Norway)

^b HAUGESUND HOSPITAL   (Norway)

^c STATOIL   (Norway)

Author keywords

Blood cells; Mean corpuscular volume; Smoking

Indexed keywords

AMINOTHIOL; CYANOCOBALAMIN; CYSTEINE; CYSTEINYLGLYCINE; FOLIC ACID; HOMOCYSTEINE;

ADULT; ARTICLE; BASOPHIL; CELL SUBPOPULATION; DRUG BLOOD LEVEL; EOSINOPHIL COUNT; ERYTHROCYTE COUNT; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; INDUSTRIAL WORKER; INFLAMMATION; LEUKOCYTE; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MONOCYTE; NEUTROPHIL COUNT; PRIORITY JOURNAL; SMOKING; VITAMIN BLOOD LEVEL; BLOOD CELL COUNT; BLOOD SAMPLING; CONTROLLED STUDY; EOSINOPHIL; ERYTHROCYTE; LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; NEUTROPHIL;

ADULT; BASOPHILS; EOSINOPHILS; ERYTHROCYTE INDICES; ERYTHROCYTES; FEMALE; FOLIC ACID; HEMOGLOBINS; HUMANS; INDUSTRY; LEUKOCYTE COUNT; LEUKOCYTES; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; OCCUPATIONAL HEALTH; SMOKING; VITAMIN B 12;

EID: 84871897161     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000345410     Document Type: Article

References (30)

1. Global Status Report on Non-Communicable Disease 2010. Description of the Global Burden of NCDs, Their Risk Factors and Determinants. Geneva, World Health Organization, 2011.
2. Libby P: Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr 2006; 83(suppl):456S-460S.
3. Hotamisligil G: Inflammation and metabolic disorders. Nature 2006; 444: 860-867.
4. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F: Markers of inflammation and cardiovascular disease: application to clinical and public health practice. A statement for health care professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511.
5. Oda E, Kawai R: The prevalence of metabolic syndrome and diabetes increases through the quartiles of white blood cell count in Japanese men and women. Intern Med 2009; 48: 1127-1134.
6. Ruggiero C, Metter JE, Cherubini A, Maggio M, Sen R, Najjar SS, Windham GB, Ble A, Senin U, Ferrucci L: White blood cell count and mortality in the Baltimore Longitudinal Study of Aging. J Am Coll Cardiol 2007; 49: 1841-1850.
7. Unverdorben M, Holt KV, Winkelmann BR: Smoking and atherosclerotic disease: Part II. Role of cigarette smoking in cardiovascular disease development. Biomarkers Med 2009; 3: 617-653.
8. Mansoor MA, Hervig T, Stakkestad JA, Drabløs PA, Apeland T, Wentzel-Larsen T, Bates CJ: Serum folate is significantly correlated with plasma cysteine concentrations in healthy industry workers. Ann Nutr Metab 2011; 58: 68-73.
9. Mansoor MA, Svardal AM, Ueland PM: Determination of the in vivo redox status of homocysteine, cysteine, cysteinylglycine, and glutathione in human plasma. Anal Biochem 1992; 92: 218-229.
10. Mansoor MA, Kristensen O, Hervig T, Stakkestad JA, Berge T, Drabløs PA, Rolfsen S, Wentzel-Larsen T: Relationship between serum folate and plasma nitrate concentrations: possible clinical implications. Clin Chem 2005; 51: 1266-1268.
11. Nordin G, Mårtensson A, Swolin B, Sandberg S, Christensen NJ, Thorsteinsson V, Franzson L, Kairisto V, Savolainen ER: A multicentre study of reference intervals for haemoglobin, basic blood cell counts and erythrocyte indices in the adult population of Nordic countries. Scand J Clin Lab Invest 2004; 64: 385-398.
12. Smith MR, Kinmonth AL, Luben RN, Bingham S, Day NE, Wareham NJ, Welch A, Khaw KT: Smoking status and differential white cell count in men and women in the EPIC-Norfolk population. Atherosclerosis 2003; 169: 331-337.
13. Freedman DS, Flanders WD, Barboriak JJ, Malarcher AM, Gates L: Cigarette smoking and leukocyte subpopulation in men. Ann Epidemiol 1996; 6: 299-306.
14. Phillips AC, Carroll D, Gale CR, Drayson M, Batty GD: Lymphocyte cell counts in middle age is positively associated with subsequent all-cause and cardiovascular mortality. QJM 2011; 104: 319-324.
15. Wannamethee SG, Lowe GDO, Shaper GA, Rumley A, Lennon L, Whincup PH: Association between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J 2005; 26: 1765-1773.
16. Harrison JE, Schultz J: Studies on the chlorinating activity of myeloperoxidase. J Biol Chem 1976; 251: 1371-1374.
17. Zhang R, Brennan ML, Shen Z, MacPherson JC, Schmitt D, Molenda CE, Hazen SL: Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation. J Biol Chem 2002; 277: 46116-46122.
18. Eiserich JP, Baldus S, Brennan ML, Ma W, Zhang C, Tousson A, Castro L, Lusis AJ, Nauseef WM, White CR, Freeman BA: Myeloperoxidase, leukocyte-derived vascular NO oxidase. Science 2002; 296-2391-2394.
19. Schindhelm RK, van der Zwan L, Teerlink T, Scheffer PG: Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification. Clin Chem 2009; 55: 1462-1470.
20. Carr AC, McCall MR, Frei B: Oxidation of LDL by myeloperoxidase and reactive nitrogen species: reaction pathways and antioxidant pathway. Arterioscler Thromb Vasc Biol 2000; 20: 1716-1723.
21. Shoji T, Hatsuda S, Tsuchikura S, Shinohara K, Kimoto E, Koyama H, Emoto M, Nishizawa Y: Small dense low-density lipoprotein cholesterol concentration and carotid atherosclerosis. Atherosclerosis 2009; 202: 582-588.
22. Shao B, Oda MN, Oram JF, Heinecke JW: Myeloperoxidase: an oxidative pathway for generating dysfunctional HDL. Chem Res Toxicol 2010; 23: 447-454.
23. Nikpoor B, Turecki G, Fournier C, Theroux P, Rouleau GA: A functional myleperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians. Am Heart J 2001; 142: 336-339.
24. Ishigaki Y, Okay, Katagiri H: Circulating oxidized LDL: a biomarker and a pathogenic factor. Curr Opin Lipidol 2009; 20: 363-369.
25. Ahn J, Gammon MD, Santella RM, Guadet MM, Britton JA, Teitelbaum SL, Terry MB, Neugut Al, Josephy PD, Ambrosone CB: Myeloperoxidase genotype, fruit and vegetable consumption, and breast cancer risk. Cancer Res 2004; 64: 7634-7639.
26. Feyler A, Voho A, Bouchardy C, Kuokkanen K, Dayer P, Hirvonen A, Benhamou S: Point: Myeloperoxidase-463G A polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2002; 11: 1550-1554.
27. Tungtongchitr R, Pongpaew P, Soonthornruengyot M, Viroonudomphol D, Vudhivai N, Tungtrongchitr A, Phonrat B, Pooudong S, Schelp FP: Relationship of tobacco smoking with serum vitamin B 12, folic acid and haematological indices in healthy adults. Public Health Nutr 2003; 7: 675-681.
28. Mansoor MA, Kristensen O, Hervig T, Drabløs PA, Stakkestad JA, Woie L, Hetland O, Osland A: Low concentrations of folate in serum and erythrocytes of smokers: methionine loading decreases folate concentrations in serum of smokers and nonsmokers. Clin Chem 1997; 43: 2192-2194.
29. Conrad Wagner: Biochemical role of folate in cellular metabolism; in Bailey LB (ed): Folate in Health and Disease. New York, Dekker, 1995, pp 23-42.
30. Haltmayer M, Mueller T, Luft C, Poelz W, Haidinger D: Erythrocyte mean corpuscular volume associated with severity of peripheral arterial disease: an angiographic evaluation. Ann Vasc Surg 2002; 16: 474-479.